|
- Boehringer Ingelheim - Life Forward
Boehringer Ingelheim is a research-driven group of companies dedicated to the discovery, development, manufacture and marketing of innovative health care products
- Boehringer Ingelheim - Wikipedia
C H Boehringer Sohn AG Co KG is the parent company of the Boehringer Ingelheim group, which was founded in 1885 by Albert Boehringer (1861–1939) in Ingelheim am Rhein, Germany
- Boehringer Labs | Innovative Medical Device for Surgical Care
We create best-in-class medical devices that elevate patient care and empower clinicians to perform at their best For over 50 years, Boehringer Laboratories has been delivering expertly engineered solutions in respiratory therapy and suction control
- Boehringer Ingelheim Pharmaceuticals - Drugs. com
Boehringer Ingelheim Pharmaceuticals, Inc manufactures, markets and or distributes more than 30 drugs in the United States Medications listed here may also be marketed under different names in different countries
- Boehringer Ingelheim pipeline: A busy year of dealmaking in 2025
Discover Boehringer Ingelheim’s pipeline focus areas and how its dealmaking in 2025 has expanded its therapeutic arsenal
- Who we are - Boehringer Ingelheim
Improving the health and quality of life of humans and animals is the goal of the research-driven pharmaceutical company Boehringer Ingelheim
- Boehringer quietly outmanoeuvres Bayer | ApexOnco - Clinical Trials . . .
Two rival HER2 inhibitors, Boehringer Ingelheim’s Hernexeos and Bayer’s Hyrnuo, have lived nearly parallel lives, scoring concurrent accelerated approvals and recently posting extremely similar results in first-line lung cancer But Boehringer has used a new US pathway – the commissioner’s national priority voucher (CNPV) programme – for a first-line Hernexeos filing, and it has just
- About Boehringer Labs | Advancing Patient Care
Learn about Boehringer Labs' mission to improve healthcare with high-quality medical devices and a commitment to excellence
|
|
|